On Nov. 17, Rev. Jesse Jackson, 76, disclosed his Parkinson's diagnosis. Dr. Michael Okun, UF neurology chair and Parkinson's Foundation medical director, says the disease is manageable with personalized treatment.
Delayed gratification research conducted by Dr. Jennifer Bizon’s lab receives Society for Neuroscience honor at world’s largest source of emerging news about brain science and health.
On Wednesday, Nov. 8, dozens of researchers from eight departments participated in the McKnight Brain Institute Research Evening — Pre-Society for Neuroscience (SfN) Data Blitz event.
Autopsy studies of dolphins washed ashore on the beaches of Spain revealed the telltale pathology of Alzheimer’s disease.
Over the last few years, there has been great interest in learning more about the proteins that accumulate in brains affected by various neurodegenerative disorders and the idea that these proteins can spread from one area of the brain to the other. Now, a team of University of Florida neuroscientists…
At the McKnight Brain Institute, teams of researchers are striving to find techniques to help multitudes of seniors to remain independent and active and enjoy life. The latest issue of Florida Physician magazine showcases how UF researchers are looking to slow or avert age-related cognitive decline. Read the story…
Researchers from a variety of disciplines at UF are on a mission to cure one of modern medicine’s least understood and most painful conditions: trigeminal neuralgia, or TN. Read the story in the latest edition of Florida Physician magazine.
Flanked by a surgery resident and a technician, surgeon Jessica Ching, M.D., holds a 3D model of a patient’s skull. She carefully turns the model over in her hands, considering just where an implant will replace a piece of missing bone. The patient is Robert Lines, 58, of Ocala,…
Duane Mitchell, M.D., Ph.D., co-director of UF’s Preston A. Wells Jr. Center for Brain Tumor Therapy and head of the Cancer Therapeutics & Immuno-Oncology program at the UF Health Cancer Center, presented a conversation about the use of immunotherapy to treat brain cancers on Monday, Feb. 13 at 6 p.m.
Melissa Armstrong, M.D., assistant professor in the department of neurology, writes in a new essay for The Conversation about the use of health care guidelines.
